Biomarker Discovery and Validation for Precision Oncology

Dear Colleagues,

The integration of biomarkers into precision oncology is revolutionizing cancer care by enabling more accurate screening, diagnosis, and personalized treatment strategies.

This Special Issue, entitled "Biomarker Discovery and Validation for Precision Oncology", aims to highlight cutting-edge research and advancements in the discovery, development, and clinical validation of biomarkers across diverse cancer types, showcasing innovative research and its translational potential.

We welcome the submission of original research, reviews, and short communications focusing on a broad range of topics, including, but not limited to, the following:

• Biomarker discovery and validation for cancer screening and diagnostics.
• Precision medicine approaches in oncology, including targeted therapies and immunotherapies.
• Non-invasive and liquid biopsy approaches, including circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), extracellular vesicles, and omics approaches.
• Development of new tools, technologies, and improved models to enhance biomarker research.
• Multi-omics integration and novel methodologies in biomarker development.
• Clinical implementation and challenges in regulatory approval of oncology biomarkers.

This Special Issue seeks to provide a platform for interdisciplinary discussions, advancing our understanding of how biomarkers can shape the future of cancer care. We encourage submissions from researchers, clinicians, and industry professionals that contribute to the growing body of knowledge in precision oncology.

Dr. Luís Lima
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.